Skip to content

Clinical trials

Completed Phase 2 Vulvar Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vulvar Neoplasms Phase: Phase 2 Status: Completed Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20051
20074
20091
20101
20111
20121
20131
20171
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dana-Farber Cancer Institute2
Gynecologic Oncology Group2
Merck Sharp & Dohme LLC2
Beijing Health Guard Biotechnology, Inc1
Case Comprehensive Cancer Center1
European Organisation for Research and Treatment of Cancer - EORTC1
Masonic Cancer Center, University of Minnesota1
NRG Oncology1
Ohio State University Comprehensive Cancer Center1
St.Gallen University of Applied Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vulvar Neoplasms15
Uterine Cervical Neoplasms11
Vaginal Neoplasms9
Endometrial Neoplasms4
Carcinoma, Ovarian Epithelial3
Condylomata Acuminata3
Fallopian Tube Neoplasms3
Ovarian Neoplasms3
Papillomavirus Infections3
Anus Neoplasms2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.